- Motley Fool•21 hours ago
Catalysts at IBM, Briggs & Stratton, and Gilead Sciences could make it the perfect time to step up and buy shares in these companies.
Biotech stocks had a rough year in 2016, overall. The new year has brought new optimism among some investors, but there are still reasons to be cautious.
- Motley Fool•2 days ago
Big pharma is reeling from President-elect Trump's press-conference comments that the industry is "getting away with murder."
GILD : Summary for Gilead Sciences, Inc. - Yahoo Finance
Gilead Sciences Inc. (GILD)
NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
|Bid||72.28 x 100|
|Ask||72.48 x 100|
|Day's Range||0.00 - 0.00|
|52 Week Range|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||6.65|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|